CA-125 and risk of malignancy index for screening for malignancy in fertile aged females with ovarian cyst, which is more cost effectiveness?

BACKGROUND: Ovarian tumor is a cause of infertility in the fertile-aged women. Also, it can also turns into malignancy and causes deadly outcome. Screening for malignancy is an important management. AIMS: The available screening methods that are widely used at present include CA-125 determination an...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764747/
https://www.ncbi.nlm.nih.gov/pubmed/24049290
http://dx.doi.org/10.4103/0971-5851.116178
Descripción
Sumario:BACKGROUND: Ovarian tumor is a cause of infertility in the fertile-aged women. Also, it can also turns into malignancy and causes deadly outcome. Screening for malignancy is an important management. AIMS: The available screening methods that are widely used at present include CA-125 determination and the risk of malignancy index (RMX), which is a combined CA-125 with ultrasonography, determination. MATERIALS AND METHODS: Here, the author tries to assess cost-effectiveness of both alternative in screening by basic medical economics technique. STATISTICS: Classical descriptive analysis was used for cost effectiveness calculation. RESULTS: In this work, from the cost-effectiveness analysis, the CA-125 test is more cost-effectiveness than RMX. CONCLUSION: This reflects that the usage of additional ultrasonography test for increasing the diagnostic activity in screening for ovarian cyst in the fertile aged females in Thailand is still not appropriate.

Ejemplares similares